3,574
Views
175
CrossRef citations to date
0
Altmetric
Research Article

Systemic toxicity related to metal hip prostheses

, &
Pages 837-847 | Received 01 May 2014, Accepted 10 Jul 2014, Published online: 16 Aug 2014

References

  • Labek G, Thaler M, Janda W, Agreiter M, Stöckl B. Revision rates after total joint replacement: cumulative results from worldwide joint register datasets. J Bone Joint Surg Br 2011; 93-B:293–297.
  • Rising JP, Reynolds IS, Sedrakyan A. Delays and difficulties in assessing metal-on-metal hip implants. N Engl J Med 2012; 367:e1.
  • Doorn PF, Campbell PA, Worrall J, Benya PD, McKellop HA, Amstutz HC. Metal wear particle characterization from metal on metal total hip replacements: transmission electron microscopy study of periprosthetic tissues and isolated particles. J Biomed Mater Res 1998; 42:103–111.
  • Brown C, Williams S, Tipper JL, Fisher J, Ingham E. Characterisation of wear particles produced by metal on metal and ceramic on metal hip prostheses under standard and microseparation simulation. J Mater Sci Mater Med 2007; 18:819–827.
  • Firkins PJ, Tipper JL, Saadatzadeh MR, Ingham E, Stone MH, Farrar R, Fisher J. Quantitative analysis of wear and wear debris from metal-on-metal hip prostheses tested in a physiological hip joint simulator. Bio-Med Mater Eng 2001; 11:143–157.
  • Gill HS, Grammatopoulos G, Adshead S, Tsialogiannis E, Tsiridis E. Molecular and immune toxicity of CoCr nanoparticles in MoM hip arthroplasty. Trends Mol Med 2012; 18:145–155.
  • NJR Editorial Board, ed. 9th Annual Report. Hemel Hempstead, Hertfordshire: National Joint Registry for England and Wales, 2012.
  • Hart AJ, Quinn PD, Sampson B, Sandison A, Atkinson KD, Skinner JA, et al. The chemical form of metallic debris in tissues surrounding metal-on-metal hips with unexplained failure. Acta Biomater 2010; 6:4439–4446.
  • Hart AJ, Sandison A, Quinn P, Sampson B, Atkinson KD, Skinner JA, et al. Microfocus study of metal distribution and speciation in tissue extracted from revised metal on metal hip implants. J Phys Conf Ser 2009; 190:012208.
  • Merritt K, Brown SA. Release of hexavalent chromium from corrosion of stainless steel and cobalt–chromium alloys. J Biomed Mater Res 1995; 29:627–633.
  • Cieslak W, Pap K, Bunch DR, Reineks E, Jackson R, Steinle R, Wang S. Highly sensitive measurement of whole blood chromium by inductively coupled plasma mass spectrometry. Clin Biochem 2013; 46:266–270.
  • Tvermoes BE, Finley BL, Unice KM, Otani JM, Paustenbach DJ, Galbraith DA. Cobalt whole blood concentrations in healthy adult male volunteers following two-weeks of ingesting a cobalt supplement. Food Chem Toxicol 2013; 53:432–439.
  • Jantzen C, Jorgensen HL, Duus BR, Sporring SL, Lauritzen JB. Chromium and cobalt ion concentrations in blood and serum following various types of metal-on-metal hip arthroplasties: a literature overview. Acta Orthop 2013; 84:229–236.
  • Daniel J, Ziaee H, Pradhan C, McMinn DJ. Six-year results of a prospective study of metal ion levels in young patients with metal-on metal hip resurfacings. J Bone Joint Surg Br 2009; 91-B:176–179.
  • Marker M, Grübl A, Riedl O, Heinze G, Pohanka E, Kotz R. Metal- on-metal hip implants: do they impair renal function in the long-term? A 10-year follow-up study. Arch Orthop Trauma Surg 2008; 128:915–919.
  • Lass R, Grubl A, Kolb A, Stelzeneder D, Pilger A, Kubista B, et al. Comparison of synovial fluid, urine, and serum ion levels in metal-on-metal total hip arthroplasty at a minimum follow-up of 18 years. J Orthop Res 2014; online early: doi:10.1002/jor.22652.
  • Kwon YM, Ostlere SJ, McLardy-Smith P, Athanasou NA, Gill HS, Murray DW. “Asymptomatic” pseudotumors after metal-on-metal hip resurfacing arthroplasty: prevalence and metal ion study. J Arthroplasty 2011; 26:511–518.
  • Davda K, Lali FV, Sampson B, Skinner JA, Hart AJ. An analysis of metal ion levels in the joint fluid of symptomatic patients with metal-on-metal hip replacements. J Bone Joint Surg Br 2011; 93-B:738–745.
  • Langton DJ, Jameson SS, Joyce TJ, Hallab NJ, Natu S, Nargol AV. Early failure of metal-on-metal bearings in hip resurfacing and large-diameter total hip replacement: a consequence of excess wear. J Bone Joint Surg Br 2010; 92:38–46.
  • De Smet K, De Haan R, Calistri A, Campbell PA, Ebramzadeh E, Pattyn C, Gill HS. Metal ion measurement as a diagnostic tool to identify problems with metal-on-metal hip resurfacing. J Bone Joint Surg Am 2008; 90:202–208.
  • Madathil BK, Lin Q, Hew C-L, Mohanty M. Hypoxia-like effect of cobalt chromium alloy micro particles on fibroblasts in vitro. J Orthop Res 2010; 28:1360–1367.
  • Kovacik MW, Mostardi RA, Neal DR, Bear TF, Askew MJ, Bender ET, et al. Differences in the surface composition of seemingly similar F75 cobalt-chromium micron-sized particulates can affect synovial fibroblast viability. Colloids Surf B Biointerfaces 2008; 65:269–275.
  • Polyzois I, Nikolopoulos D, Michos I, Patsouris E, Theocharis S. Local and systemic toxicity of nanoscale debris particles in total hip arthroplasty. J Appl Toxicol 2012; 32:255–269.
  • Andrews RE, Shah KM, Wilkinson JM, Gartland A. Effects of cobalt and chromium ions at clinically equivalent concentrations after metal-on-metal hip replacement on human osteoblasts and osteoclasts: Implications for skeletal health. Bone 2011; 49:717–723.
  • Xia Z, Kwon Y-M, Mehmood S, Downing C, Jurkschat K, Murray DW. Characterization of metal-wear nanoparticles in pseudotumor following metal-on-metal hip resurfacing. Nanomedicine 2011; 7:674–681.
  • Willert HG, Buchhorn GH, Fayyazi A, Flury R, Windler M, Köster G, Lohmann CH. Metal-on-metal bearings and hypersensitivity in patients with artificial hip joints: a clinical and histomorphological study. J Bone Joint Surg Am 2005; 87:28–36.
  • Keel SB, Jaffe KA, Nielsen GP, Rosenberg AE. Orthopaedic implant-related sarcoma: a study of twelve cases. Mod Pathol 2001; 14:969–977.
  • Leikin JB, Karydes HC, Whiteley PM, Wills BK, Cumpston KL, Jacobs JJ. Outpatient toxicology clinic experience of patients with hip implants. Clin Toxicol 2013; 51:230–236.
  • Zywiel MG, Brandt JM, Overgaard CB, Cheung AC, Turgeon TR, Syed KA. Fatal cardiomyopathy after revision total hip replacement for fracture of a ceramic liner. Bone Joint J 2013; 95-B:31–37.
  • Steens W, Von Foerster G, Katzer A. Severe cobalt poisoning with loss of sight after ceramic-metal pairing in a hip – A case report. Acta Orthop 2006; 77:830–832.
  • Steens W, Loehr JF, Von Foerster G, Katzer A. Chronische Kobaltvergiftung in der Endoprothetik. Ein Fallbericht. Orthopade 2006; 35:860–864.
  • Gilbert CJ, Cheung A, Butany J, Zywiel MG, Syed K, McDonald M, et al. Hip pain and heart failure: the missing link. Can J Cardiol 2013; 29:639.
  • Tower SS. Arthroprosthetic cobaltism: neurological and cardiac manifestations in two patients with metal-on-metal arthroplasty: a case report. J Bone Joint Surg [Am] 2010; 92:2847–2851.
  • Tower S. Arthroprosthetic cobaltism: identification of the at-risk patient. Alaska Med 2010; 52:28–32.
  • Tower S. Cobalt toxicity in two hip replacement patients. State Alaska Epidemiol Bull 2010; 14:1.
  • Sotos JG, Tower SS. Systemic disease after hip replacement: aeromedical implications of arthroprosthetic cobaltism. Aviat Space Environ Med 2013; 84:242–245.
  • Giampreti A, Lonati D, Locatelli CA. Reply to letter by Devlin et al.–Chelation in suspected prosthetic hip-associated cobalt toxicity. Can J Cardiol 2014; 30:465.e13.
  • Giampreti A, Lonati D, Vecchio S, Petrolini VM, Basso V, Zerbini F, et al. Chelation therapy with intravenous high dose N-acetyl-cysteine for cobalt release from metal on metal hip replacement: a first case report. Clin Toxicol 2013; 51:361.
  • Pazzaglia UE, Apostoli P, Congiu T, Catalani S, Marchese M, Zarattini G. Cobalt, chromium and molybdenum ions kinetics in the human body: data gained from a total hip replacement with massive third body wear of the head and neuropathy by cobalt intoxication. Arch Orthop Trauma Surg 2011; 131:1299–1308.
  • Rizzetti MC, Liberini P, Zarattini G, Catalani S, Pazzaglia U, Apostoli P, Padovani A. Loss of sight and sound. Could it be the hip? Lancet 2009; 373:1052.
  • Catalani S, Leone R, Rizzetti MC, Padovani A, Apostoli P. The role of albumin in human toxicology of cobalt: contribution from a clinical case. ISRN Hematol 2011; 2011:690620.
  • Rizzetti MC, Catalani S, Apostoli P, Padovani A. Cobalt toxicity after total hip replacement: a neglected adverse effect? Muscle Nerve 2011; 43:146–147.
  • Rizzetti MC, Liberini P, Agosti C, Catalani S, Apostoli P, Zarattini G, De Maria G. Blindness, deafness and polyneuropathy: a case of cobalt neurotoxicity. Eur J Neurol 2009; 16:323.
  • Rizzetti MC, Liberini P, Agosti C, Catalani S, Apostoli P, Padovani A. Cobalt neurotoxicity: a lesson from hip arthroplasty. J Neurol 2009; 256:S94.
  • Ikeda T, Takahashi K, Kabata T, Sakagoshi D, Tomita K, Yamada M. Polyneuropathy caused by cobalt-chromium metallosis after total hip replacement. Muscle Nerve 2010; 42:140–143.
  • Oldenburg M, Wegner R, Baur X. Severe cobalt intoxication due to prosthesis wear in repeated total hip arthroplasty. J Arthroplasty 2009; 24:825.
  • Pelclova D, Sklensky M, Janicek P, Lach K. Severe cobalt intoxication following hip replacement revision: clinical features and outcome. Clin Toxicol 2012; 50:262–265.
  • Apel W, Stark D, Stark A, O’Hagan S, Ling J. Cobalt–chromium toxic retinopathy case study. Doc Ophthalmol 2013; 126:69–78.
  • Ng SK, Ebneter A, Gilhotra JS. Hip-implant related chorio-retinal cobalt toxicity. Indian J Ophthalmol 2013; 61:35–37.
  • Megaterio S, Galetto F, Alossa E, Capretto S. Effetti a distanza del rilascio di ioni metallo in usura della testa protesica: presentazione di un caso. Giornale Italiano di Ortopedia e Traumatologia 2001; 27:173–175.
  • Machado C, Appelbe A, Wood R. Arthroprosthetic cobaltism and cardiomyopathy. Heart Lung Circ 2012; 21:759–760.
  • Mao X, Wong AA, Crawford RW. Cobalt toxicity — an emerging clinical problem in patients with metal-on-metal hip prostheses? Med J Aust 2011; 194:649–651.
  • Allen LA, Ambardekar AV, Devaraj KM, Maleszewski JJ, Wolfel EE. Clinical problem-solving. Missing elements of the history. N Engl J Med 2014; 370:559–566.
  • Dahms K, Sharkova Y, Heitland P, Pankuweit S, Schaefer JR. Cobalt intoxication diagnosed with the help of Dr House. Lancet 2014; 383:574.
  • Paustenbach DJ, Tvermoes BE, Unice KM, Finley BL, Kerger BD. A review of the health hazards posed by cobalt. Crit Rev Toxicol 2013; 43:316–362.
  • Schirrmacher UOE. Case of cobalt poisoning. Br Med J 1967; 1: 544–545.
  • Bowie EA, Hurley PJ. Cobalt chloride in the treatment of refractory anaemia in patients undergoing long-term haemodialysis. Aust N Z J Med 1975; 5:306–313.
  • Meecham HM, Humphrey P. Industrial exposure to cobalt causing optic atrophy and nerve deafness: a case report. J Neurol Neurosurg Psychiatry 1991; 54:374–375.
  • Apostoli P, Catalani S, Zaghini A, Mariotti A, Poliani PL, Vielmi V, et al. High doses of cobalt induce optic and auditory neuropathy. Exp Toxicol Pathol 2013; 65:719–727.
  • Licht A, Oliver M, Rachmilewitz EA. Optic atrophy following treatment with cobalt chloride in a patient with pancytopenia and hypercellular marrow. Isr J Med Sci 1972; 8:61–66.
  • Bhardwaj N, Perez J, Peden M. Optic neuropathy from cobalt toxicity in a patient who ingested cattle magnets. Neuroophthalmology 2011; 35:24–26.
  • Hara A, Niwa M, Aoki H, Kumada M, Kunisada T, Oyama T, et al. A new model of retinal photoreceptor cell degeneration induced by a chemical hypoxia-mimicking agent, cobalt chloride. Brain Res 2006; 1109:192–200.
  • Alexander CS. Cobalt-beer cardiomyopathy. A clinical and pathologic study of twenty-eight cases. Am J Med 1972; 53:395–417.
  • Prentice JR, Clark MJ, Hoggard N, Morton AC, Tooth C, Paley MN, et al. Metal-on-metal hip prostheses and systemic health: a cross- sectional association study 8 years after implantation. PLoS ONE 2013; 8:e66186.
  • Kriss JP, Carnes WH, Gross RT. Hypothyroidism and thyroid hyperplasia in patients treated with cobalt. JAMA 1955; 157: 117–121.
  • Bianchi C, Bertanza C, Mistura L, Pietra R, Sabbioni E. Cobalt-induced hypothyroidism, cardiomyopathy, polycythemia, and hypertricosis in an infant. J Trace Elem Exp Med 1989; 2: 311–319.
  • Smith SW. The role of chelation in the treatment of other metal poisonings. J Med Toxicol 2013; 9:355–369.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.